Why precision medicines for oncology demands precision engagement

MedCity News | May 24, 2019

Life sciences companies overwhelmed with large volumes of information and data available – both in terms of therapies and patient-reported outcomes – must establish a more efficient, bi-directional communication model with care teams to succeed.

Read more ›